|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 99, 911-918, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
HF McAlister, RA Luke, RM Whitlock and WM Smith
The safety and efficacy of amiodarone and quinidine in reverting atrial
tachyarrhythmias after cardiac operations were compared in a randomized
cross-over trial. Patients with sustained atrial fibrillation or flutter
for more than 2 hours' duration, stable hemodynamic status, and prior
digoxin therapy were randomized to receive either intravenous amiodarone, 5
mg/kg over 20 minutes (41 patients), or oral quinidine, 400 mg immediately
and 400 mg in 4 hours (39 patients), with cross-over at 8 hours if
reversion was not achieved. Thirty-six patients had a coronary artery
operation, 35 a valvular operation, five had both, and there were four
miscellaneous cases. There was a male:female ratio of 1.5:1 and a mean age
of 58 years (range 23 to 75 years). Preoperative atrial fibrillation or
flutter was present in nine patients, and four patients had an ejection
fraction less than 40%. Twenty-five of 39 patients (64%) given quinidine
first reverted to sinus rhythm, compared with 17 of 41 patients (41%) given
amiodarone first (2p = 0.04). Side- effects occurred in 18 patients given
quinidine and five patients given amiodarone (2p = 0.01). Two patients,
both given quinidine, were withdrawn from the study. There was no
correlation, with either drug, between serum levels and clinical efficacy.
Multivariate analysis identified longer times from arrhythmia to treatment,
preoperative atrial fibrillation, mitral valve operations, and concomitant
propranolol therapy as factors predictive of failure to revert to sinus
rhythm. Oral quinidine was more effective than intravenous amiodarone in
reverting postoperative atrial fibrillation and flutter but caused more
side-effects.
ARTICLES
Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations
Department of Cardiology, Green Lane Hospital, Auckland, New Zealand.
This article has been cited by other articles:
![]() |
J. Dunning, T. Treasure, M. Versteegh, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 852 - 872. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF] |
||||
![]() |
E. A. Martinez, E. B. Bass, and P. Zimetbaum Pharmacologic Control of Rhythm: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery Chest, August 1, 2005; 128(2_suppl): 48S - 55S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rosborough, M. Hravnak, L. A. Hoffman, M. I. Saul, T. G. Zullo, and G. R. Whitman Resource utilization related to atrial fibrillation after coronary artery bypass grafting (May 2002:228-238). Am. J. Crit. Care., November 1, 2002; 11(6): 501 - 501. [Full Text] [PDF] |
||||
![]() |
G Nichol, F McAlister, B Pham, A Laupacis, B Shea, M Green, A Tang, and G Wells Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation Heart, June 1, 2002; 87(6): 535 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Maisel, J. D. Rawn, and W. G. Stevenson Atrial Fibrillation after Cardiac Surgery Ann Intern Med, December 18, 2001; 135(12): 1061 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266. [Full Text] [PDF] |
||||
![]() |
H. Dorge, F. A. Schoendube, M. Schoberer, C. Stellbrink, M. Voss, and B. J. Messmer Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations Ann. Thorac. Surg., May 1, 2000; 69(5): 1358 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hogue Jr and M. L. Hyder Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment Ann. Thorac. Surg., January 1, 2000; 69(1): 300 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Connolly Evidence-Based Analysis of Amiodarone Efficacy and Safety Circulation, November 9, 1999; 100(19): 2025 - 2034. [Full Text] [PDF] |
||||
![]() |
K. Katariya, E. DeMarchena, and H. Bolooki Oral amiodarone reduces incidence of postoperative atrial fibrillation Ann. Thorac. Surg., November 1, 1999; 68(5): 1599 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kreiss, Y. Sidi, and H. Gur Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department Postgrad. Med. J., May 1, 1999; 75(883): 278 - 281. [Abstract] [Full Text] |
||||
![]() |
P. Kleine, D. Blommaert, G. van Nooten, O. Blin, G. Haisch, W. Stoffelen, D. Reuter, and A. Liebold Multicenter results of TADpoleTM heart wire system used to treat postoperative atrial fibrillation Eur. J. Cardiothorac. Surg., April 1, 1999; 15(4): 525 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Singh, B. Lopez, and J. S.M. Sarma Significance and Prevention of Atrial Fibrillation Occurring After Cardiac Surgery: A Time for Fundamental Change in Strategy? Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(3): 259 - 267. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |